- Home
- RVPH vs ZYBT Comparison
RVPH vs ZYBT Comparison
Compare RVPH & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- ZYBT
- Stock Information
- Founded
- RVPH 2006
- ZYBT 2004
- Country
- RVPH United States
- ZYBT China
- Employees
- RVPH N/A
- ZYBT N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- ZYBT
- Sector
- RVPH Health Care
- ZYBT
- Exchange
- RVPH Nasdaq
- ZYBT NYSE
- Market Cap
- RVPH 32.8M
- ZYBT 340.3M
- IPO Year
- RVPH N/A
- ZYBT 2025
- Fundamental
- Price
- RVPH $0.39
- ZYBT $5.58
- Analyst Decision
- RVPH Strong Buy
- ZYBT
- Analyst Count
- RVPH 5
- ZYBT 0
- Target Price
- RVPH $9.00
- ZYBT N/A
- AVG Volume (30 Days)
- RVPH 3.7M
- ZYBT 223.5K
- Earning Date
- RVPH 08-13-2025
- ZYBT 07-03-2025
- Dividend Yield
- RVPH N/A
- ZYBT N/A
- EPS Growth
- RVPH N/A
- ZYBT N/A
- EPS
- RVPH N/A
- ZYBT 0.03
- Revenue
- RVPH N/A
- ZYBT $25,531,367.00
- Revenue This Year
- RVPH N/A
- ZYBT N/A
- Revenue Next Year
- RVPH N/A
- ZYBT N/A
- P/E Ratio
- RVPH N/A
- ZYBT $172.98
- Revenue Growth
- RVPH N/A
- ZYBT N/A
- 52 Week Low
- RVPH $0.30
- ZYBT $3.50
- 52 Week High
- RVPH $4.28
- ZYBT $14.30
- Technical
- Relative Strength Index (RSI)
- RVPH 35.22
- ZYBT N/A
- Support Level
- RVPH $0.38
- ZYBT N/A
- Resistance Level
- RVPH $0.45
- ZYBT N/A
- Average True Range (ATR)
- RVPH 0.05
- ZYBT 0.00
- MACD
- RVPH 0.01
- ZYBT 0.00
- Stochastic Oscillator
- RVPH 17.57
- ZYBT 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.